Christopher A. Powers, PharmD
Articles
August 26th 2017
Impact of Formulary Restrictions on Medication Use and Costs
Xian Shen, PhD Bruce C. Stuart, PhD Christopher A. Powers, PharmD Sarah E. Tom, PhD, MPH Laurence S. Magder, PhD Eleanor M. Perfetto, PhD, MS
Placing formulary restrictions on brand name drugs shifts use toward generics, lowers the cost per prescription fill, and has minimal impact on overall adherence for antidiabetes, antihyperlipidemia, and antihypertension medications among low-income subsidy recipients in Medicare Part D plans.
May 11th 2015
Observation Encounters and Subsequent Nursing Facility Stays
Anita A. Vashi, MD, MPH, MHS Susannah G. Cafardi, MSW, LCSW, MPH Christopher A. Powers, PharmD Joseph S. Ross, MD, MHS William H. Shrank, MD, MSHS
Only 1.2% of community-dwelling Medicare beneficiaries who received hospital-based observation services in 2010 were discharged to an SNF not covered by Medicare.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: December 19th 2024 | Updated: December 26th 2024
The Dangerous Intersection of Breast Cancer and Cardiovascular Disease: A Call for Improved Prevention
